Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.32
-0.3200-2.35%
Post-market: 13.320.00000.00%16:10 EDT
Volume:97.05K
Turnover:1.29M
Market Cap:227.85M
PE:-3.45
High:13.55
Open:13.53
Low:13.10
Close:13.64
52wk High:16.77
52wk Low:11.13
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.68
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:1.06
PE(LYR):-4.17

Loading ...

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation

GlobeNewswire
·
Apr 28

Wave Life Sciences Reports Q1 Results, Advances RNA Pipeline

TIPRANKS
·
Apr 28

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Apr 28

Circio’s circVec Gene Therapy Platform Wins Spotlight at Global ASGCT Meeting

TIPRANKS
·
Apr 28

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Dow Jones
·
Apr 28

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload

GlobeNewswire
·
Apr 27

Press Release: TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University

Dow Jones
·
Apr 27

BUZZ-U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks

Reuters
·
Apr 24

Atrium Therapeutics earns $15 million milestone payment from Bristol Myers Squibb

Reuters
·
Apr 23

Atrium Therapeutics Inc - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS
·
Apr 23

Atrium Therapeutics Earns $15 Million Milestone Payment From Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS
·
Apr 23

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Clinical, Regulatory, Commercialization Activities From Collaboration

THOMSON REUTERS
·
Apr 23

Perth biotech at cutting edge of the future of medicine

The West Australian
·
Apr 23

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

GlobeNewswire
·
Apr 22

Atrium Therapeutics grants inducement equity awards to seven new hires under Nasdaq rule

Reuters
·
Apr 21

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 21

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

GlobeNewswire
·
Apr 16

Circio clears 2025 reports as funding extends RNA platform runway to 2030

TIPRANKS
·
Apr 16

Circio adjusts equity incentives to offset dilution from NOK 50 million rights issue

TIPRANKS
·
Apr 16

Microbix Showcases Novel RNA Assay Controls at ESCMID Global 2026

TIPRANKS
·
Apr 15